What this determination does
The federal Department of Health, Disability and Ageing has registered a determination under the National Health Act 1953 that sets a weighted average disclosed price reduction applying from October 2026. The determination affects how pharmaceutical products are priced under government programs.
Registration details
The determination was registered on 29 June 2026 and is currently in force.
What the source does not specify
The source does not detail which specific drugs or product categories are affected, nor does it state the actual price reduction percentages or any further detail beyond the title and registration.
Where to find more information
The full determination text is available at the Federal Register of Legislation: https://www.legislation.gov.au/F2026L00860. That document sets out which products and prices are affected from October 2026.
The Department of Health, Disability and Ageing is the administering body for this determination. The source does not provide a contact email or phone number.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.